Item Type | Name |
Concept
|
Psychiatric Status Rating Scales
|
Academic Article
|
Personality disorders in patients with panic disorder: association with childhood anxiety disorders, early trauma, comorbidity, and chronicity.
|
Academic Article
|
Alcohol dependence in panic disorder patients.
|
Academic Article
|
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
|
Academic Article
|
The antidepressant potential of oral S-adenosyl-l-methionine.
|
Academic Article
|
Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant.
|
Academic Article
|
Clonazepam for the treatment of social phobia.
|
Academic Article
|
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study.
|
Academic Article
|
Enhancement of ECT benefit by yohimbine.
|
Academic Article
|
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
|
Academic Article
|
EEG abnormalities in patients with atypical panic attacks.
|
Academic Article
|
Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
|
Academic Article
|
Cognitive behavior therapy for treatment-refractory panic disorder.
|
Academic Article
|
Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder.
|
Academic Article
|
Prevalence of panic in patients referred for pulmonary function testing at a major medical center.
|
Academic Article
|
Relationship of childhood anxiety to adult panic disorder: correlates and influence on course.
|
Academic Article
|
Moclobemide in social phobia: a controlled dose-response trial.
|
Academic Article
|
Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
|
Academic Article
|
Prevalence of body dysmorphic disorder in patients with anxiety disorders.
|
Academic Article
|
Social phobia: an update.
|
Academic Article
|
Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder.
|
Academic Article
|
Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
|
Academic Article
|
Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
|
Academic Article
|
Nefazodone for social phobia: a clinical case series.
|
Academic Article
|
Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
|
Academic Article
|
Quality of life in patients with panic disorder.
|
Academic Article
|
Cell-surface expression of L-selectin (CD62L) by blood lymphocytes: correlates with affective parameters and severity of panic disorder.
|
Academic Article
|
History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder.
|
Academic Article
|
Placebo-controlled study of gabapentin treatment of panic disorder.
|
Academic Article
|
Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
|
Academic Article
|
History of childhood abuse in panic disorder, social phobia, and generalized anxiety disorder.
|
Academic Article
|
Prevalence and correlates of panic attacks in postmenopausal women: results from an ancillary study to the Women's Health Initiative.
|
Academic Article
|
Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study.
|
Academic Article
|
Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial.
|
Academic Article
|
An open-label study of levetiracetam for the treatment of social anxiety disorder.
|
Academic Article
|
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
|
Academic Article
|
Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
|
Academic Article
|
Does recovery from substance use disorder matter in patients with bipolar disorder?
|
Academic Article
|
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
|
Academic Article
|
Complicated grief and its correlates in patients with bipolar disorder.
|
Academic Article
|
Childhood antecedents to panic disorder in referred and nonreferred adults.
|
Academic Article
|
Anxiety sensitivity in traumatized Cambodian refugees: a discriminant function and factor analytic investigation.
|
Academic Article
|
Prefrontal and temporal gray matter density decreases in opiate dependence.
|
Academic Article
|
The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study.
|
Academic Article
|
An open-label trial of risperidone augmentation for refractory anxiety disorders.
|
Academic Article
|
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder.
|
Academic Article
|
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders.
|
Academic Article
|
The relationship of anxiety disorders, anxiety sensitivity and pulmonary dysfunction with dyspnea-related distress and avoidance.
|
Academic Article
|
Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder.
|
Academic Article
|
The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder.
|
Academic Article
|
A detailed examination of cytokine abnormalities in Major Depressive Disorder.
|
Academic Article
|
Anxiety is associated with impulsivity in bipolar disorder.
|
Academic Article
|
Complicated grief and impaired sleep in patients with bipolar disorder.
|
Academic Article
|
Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
|
Academic Article
|
Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint.
|
Academic Article
|
Redefining affective disorders: relevance for drug development.
|
Academic Article
|
Anger, PTSD, and the nuclear family: a study of Cambodian refugees.
|
Academic Article
|
Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
|
Academic Article
|
Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
|
Academic Article
|
Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial.
|
Academic Article
|
A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders.
|
Academic Article
|
The role of anxiety sensitivity in sleep disturbance in panic disorder.
|
Academic Article
|
Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation.
|
Academic Article
|
Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
|
Academic Article
|
Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery.
|
Academic Article
|
Augmentation of exposure therapy with post-session administration of D-cycloserine.
|
Academic Article
|
D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.
|
Academic Article
|
Voxel-based morphometric gray matter correlates of posttraumatic stress disorder.
|
Academic Article
|
Sleep quality predicts treatment outcome in CBT for social anxiety disorder.
|
Academic Article
|
Influence of RGS2 on sertraline treatment for social anxiety disorder.
|
Academic Article
|
Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
|
Academic Article
|
Negative Posttrauma Cognitions Mediate the Association Between Morally Injurious Events and Trauma-Related Psychopathology in Treatment-Seeking Veterans.
|